(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-03 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 2664602
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Mon Jun 2024 | 1.07 | 1.10 | 1.15 | 1.05 | 0.837 times |
| 31 Fri May 2024 | 1.13 | 1.15 | 1.18 | 1.04 | 5.6 times |
| 30 Thu May 2024 | 1.01 | 1.05 | 1.07 | 1.00 | 1.472 times |
| 29 Wed May 2024 | 1.01 | 1.03 | 1.04 | 1.00 | 0.311 times |
| 28 Tue May 2024 | 1.04 | 1.08 | 1.10 | 1.02 | 0.409 times |
| 23 Thu May 2024 | 1.01 | 1.05 | 1.06 | 1.01 | 0.3 times |
| 22 Wed May 2024 | 1.05 | 1.08 | 1.12 | 1.05 | 0.276 times |
| 21 Tue May 2024 | 1.08 | 1.09 | 1.11 | 1.06 | 0.493 times |
| 20 Mon May 2024 | 1.10 | 1.12 | 1.12 | 1.05 | 0.261 times |
| 17 Fri May 2024 | 1.11 | 1.16 | 1.17 | 1.10 | 0.394 times |
My analysis of stock is bearish for shortterm, and stock might move down till 1 or till 1. Use a stoploss of 1.11 and if the stock hits stoploss, then it can shoot up till 1.17
Share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Target | 0.87 |
| Downside Target | 0.92 |
| Downside Target | 1.00 |
| Downside Target | 1.05 |
| Upside Target | 1.10 |
| Upside Target | 1.15 |
| Upside Target | 1.18 |
| Upside Target | 1.23 |
| Upside Target | 1.24 |
| Upside Target | 1.34 |
| Upside Target | 1.55 |
| Upside Target | 1.79 |
| Upside Target | 2.05 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Intraday Target | 1.03 |
| Downside Intraday Target | 0.99 |
| Upside Intraday Target | 1.13 |
| Upside Intraday Target | 1.19 |
| Upside Intraday Target | 1.09 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Mon Jun 2024 | 1.07 | 1.10 | 1.15 | 1.05 | 0.107 times |
| 31 Fri May 2024 | 1.13 | 1.08 | 1.18 | 1.00 | 5.858 times |
| 23 Thu May 2024 | 1.01 | 1.12 | 1.12 | 1.01 | 0.751 times |
| 17 Fri May 2024 | 1.11 | 1.12 | 1.34 | 1.10 | 1.078 times |
| 10 Fri May 2024 | 1.12 | 1.23 | 1.23 | 1.02 | 1.022 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Mon Jun 2024 | 1.07 | 1.10 | 1.15 | 1.05 | 0.062 times |
| 31 Fri May 2024 | 1.13 | 1.19 | 1.34 | 1.00 | 1.279 times |
| 30 Tue Apr 2024 | 1.19 | 1.55 | 1.55 | 0.87 | 0.71 times |
| 28 Thu Mar 2024 | 1.58 | 1.56 | 2.05 | 1.24 | 1.055 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.09 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.09 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.